SCHEDULE 13G/A
Statement of Beneficial Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001104659-26-128329
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Rubric Capital Management LP | 2,813,469 | 5.83% |
| David Rosen | 2,813,469 | 5.83% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…